<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0864-2125</journal-id>
<journal-title><![CDATA[Revista Cubana de Medicina General Integral]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Med Gen Integr]]></abbrev-journal-title>
<issn>0864-2125</issn>
<publisher>
<publisher-name><![CDATA[ECIMED]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0864-21252020000300011</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Hipercolesterolemia en el adulto mayor]]></article-title>
<article-title xml:lang="en"><![CDATA[Hypercholesterolemia in the Older Adult]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Chang Calderin]]></surname>
<given-names><![CDATA[Omarys]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Figueredo Villa]]></surname>
<given-names><![CDATA[Katiuska]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Murillo Pulgar]]></surname>
<given-names><![CDATA[Tania Jacqueline]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Nacional de Chimborazo  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Ecuador</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2020</year>
</pub-date>
<volume>36</volume>
<numero>3</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0864-21252020000300011&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0864-21252020000300011&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0864-21252020000300011&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: La hipercolesterolemia está asociada a enfermedades cardiovasculares en la población adulta mayor y, además, a factores de riesgo como: edad, esperanza de vida y capacidad funcional. El envejecimiento como transformación social del siglo XXI constituye una situación epidemiológica relacionada con los factores de riesgo de las enfermedades cardiovasculares, se clasifican en modificables (hipertensión arterial, niveles elevados de colesterol, tabaquismo, obesidad) y no modificables (edad, sexo, antecedentes familiares). El tabaquismo potencia esta enfermedad, al igual que la hipertensión arterial multiplicando las limitaciones funcionales.  Objetivo: Describir la hipercolesterolemia como factor de riesgo cardiovascular en adultos mayores.  Métodos: Se realizó un estudio de revisión bibliográfica mediante la consulta sistemática de artículos y libros publicados en bases de datos electrónicos como: PubMed, Scielo, Dialnet, Cochrane plus, Redalyc, Elsevier, además de organismos nacionales e internacionales, durante el periodo enero-junio 2019. Para la búsqueda de información se utilizaron descriptores en salud como hipercolesterolemia, adulto mayor, factores de riesgo y boleano (and). También se consultaron páginas web como: Organization for Economic Cooperation and Development, Cardiovascular disease and diabetes, American Diabetes Association, Cardiovascular Disease and Risk Management.  Conclusiones: La hipercolesterolemia constituye un factor de riesgo modificable, por tanto, se recomienda establecer estrategias de prevención que modifiquen de manera positiva el estilo de vida del adulto mayor. Además, la utilización de estatinas debe ser en dosis de baja a moderada intensidad, considerando las interacciones farmacológicas y efectos adversos, presencia de comorbilidades y expectativa de vida.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction: Hypercholesterolemia is associated with cardiovascular diseases in the elderly population and, also, with risk factors such as age, life expectancy, and functional capacity. Aging as a social transformation of the twenty-first century constitutes an epidemiological situation related with the risk factors for cardiovascular disease. They are classified as modifiable (high blood pressure, high cholesterol levels, smoking, obesity) and non-modifiable (age, sex, family history). Smoking potentiates this disease, as does high blood pressure by multiplying functional limitations.  Objective: To describe hypercholesterolemia as a cardiovascular risk factor in older adults.  Methods: A bibliographic review study was carried out through systematic consultation of articles and books published in electronic databases such as PubMed, Scielo, Dialnet, Cochrane plus, Redalyc, Elsevier, in addition to national and international organizations, during the period from January to June 2019. In order to search for the information, health descriptors were used, such as hipercolesterolemia [hypercholesterolemia], adulto mayor [older adults], factores de riesgo [risk factors], together with the Boolean operator and. We also consulted websites such as the Organization for Economic Cooperation and Development, Cardiovascular disease and diabetes, American Diabetes Association, Cardiovascular Disease and Risk Management.  Conclusions: Hypercholesterolemia is a modifiable risk factor; therefore, it is recommended to establish prevention strategies that modify the lifestyle of the older adults positively. Furthermore, statins should be used in doses of low to moderate intensity, considering the pharmacological interactions and adverse effects, as well as presence of comorbidities and life expectancy.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[hipercolesterolemia]]></kwd>
<kwd lng="es"><![CDATA[adulto mayor]]></kwd>
<kwd lng="es"><![CDATA[factores de riesgo]]></kwd>
<kwd lng="en"><![CDATA[hypercholesterolemia]]></kwd>
<kwd lng="en"><![CDATA[older adult]]></kwd>
<kwd lng="en"><![CDATA[risk factors]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Galvis Pérez]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de dislipidemias en una institución prestadora de servicios de salud de Medellín (Colombia), 2013]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Barona Acevedo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cardona-Arias]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev CES Med]]></source>
<year>2016</year>
<volume>30</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-13</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<collab>Observatorio Mundial de la Salud (GHO)</collab>
<source><![CDATA[Colesterol elevado. Situación y tendencias]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arellano]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Barquera]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Barriguete]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lara]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rosas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Protocolo clínico para el diagnóstico y tratamiento de las Dislipidemias]]></source>
<year>2011</year>
<edition>2da. ed</edition>
<publisher-loc><![CDATA[D.F. México ]]></publisher-loc>
<publisher-name><![CDATA[CENAPRECE, Secretaria de Salud,]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ajufo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recent advances in the pharmacological management of hypercholesterolaemia]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Rader]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet Diabetes Endocrinol]]></source>
<year>2016</year>
<volume>4</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>436-46</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The new dyslipidemia guidelines: what is the debate?]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Mancini]]></surname>
<given-names><![CDATA[GB]]></given-names>
</name>
<name>
<surname><![CDATA[Genest Jr]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Grégoire]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lonn]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Hegele]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<source><![CDATA[Can J Cardiol]]></source>
<year>2015</year>
<volume>31</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>605-12</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bays]]></surname>
<given-names><![CDATA[HE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A lipidologist perspective of global lipid guidelines and recommendations, part 1: Lipid treatment targets and risk assessment]]></article-title>
<source><![CDATA[J Clin Lipidol]]></source>
<year>2016</year>
<volume>10</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>228-39</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bays]]></surname>
<given-names><![CDATA[HEE]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[PH]]></given-names>
</name>
<name>
<surname><![CDATA[Orringer]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[WV]]></given-names>
</name>
<name>
<surname><![CDATA[Jacobson]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[National Lipid Association Annual Summary of Clinical Lipidology 2016]]></article-title>
<source><![CDATA[J Clin Lipidol]]></source>
<year>2016</year>
<volume>10</volume>
<numero>1^sSuppl</numero>
<issue>1^sSuppl</issue>
<supplement>Suppl</supplement>
<page-range>S1-S43</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ble]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hughes]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Masoli]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Bowman]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Zirk-Sadowski]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Safety and Effectiveness of Statins for Prevention of Recurrent Myocardial Infarction in 12 156 Typical Older Patients: A Quasi-Experimental Study]]></article-title>
<source><![CDATA[J Gerontol A Biol Sci Med Sci]]></source>
<year>2017</year>
<volume>72</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>243-50</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Artiles]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Metodología de la Investigación para las Ciencias de la Salud]]></source>
<year>2009</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández Sampieri]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Metodología de la Investigación]]></source>
<year>2014</year>
<edition>6ta. ed</edition>
<publisher-loc><![CDATA[México DF ]]></publisher-loc>
<publisher-name><![CDATA[Interamericana Editores, SA. DE C.V]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<collab>Naciones unidas</collab>
<source><![CDATA[Envejecimiento]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Laura]]></surname>
<given-names><![CDATA[Ruiz Rivera]]></given-names>
</name>
</person-group>
<source><![CDATA[La hipercolesterolemia como factor de riesgo cardiovascular]]></source>
<year>2016</year>
<publisher-name><![CDATA[Universidad Sevilla]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bou Malham]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiovascular risk reduction: the future of cholesterol lowering drugs]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Goldberg]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
</person-group>
<source><![CDATA[Curr Opin Pharmacol]]></source>
<year>2016</year>
<volume>27</volume>
<page-range>62-9</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<collab>OECD</collab>
<collab>Organization for Economic Cooperation and Development</collab>
<source><![CDATA[Cardiovascular disease and diabetes: Policies for better health and quality of care]]></source>
<year>2015</year>
<publisher-name><![CDATA[In series: OECD Health Policies Studies]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miguel]]></surname>
<given-names><![CDATA[Serra Valdés]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Las enfermedades crónicas no transmisibles: una mirada actual ante el reto]]></article-title>
<source><![CDATA[Rev. Finlay]]></source>
<year>2016</year>
<volume>6</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>167-9</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casado]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Perfil lipídico en mayores de 65 años.: Prevalencia de hipercolesterolemia y factores de riesgo cardiovascular]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Campos]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Moron]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[José]]></surname>
<given-names><![CDATA[Solis]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Med Hered]]></source>
<year>1996</year>
<volume>7</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>125-31</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<collab>ADA. American Diabetes Association</collab>
<article-title xml:lang=""><![CDATA[Cardiovascular Disease and Risk Management]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2016</year>
<volume>39</volume>
<numero>^sSuppl 1</numero>
<issue>^sSuppl 1</issue>
<supplement>Suppl 1</supplement>
<page-range>S1-2</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosenson]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<source><![CDATA[Treatment of lipids (including hypercholesterolemia) in secondary prevention]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soto]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estatinas en adultos mayores, una población creciente]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Loza]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[KG]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Reyesb]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Fanghänel]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Revista de la Facultad de Medicina de La Universidad Nacional Autónoma de México (UNAM)]]></source>
<year>2013</year>
<volume>56</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[w]]></surname>
<given-names><![CDATA[Michael]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rich. Respuesta de Michael W. Rich]]></article-title>
<source><![CDATA[Journal of American Geriatrics society]]></source>
<year>2014</year>
<volume>62</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="book">
<collab>Grupo de Trabajo de Atención al Mayor de la semFYC</collab>
<source><![CDATA[Atención a las personas mayores desde la atención primaria]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Sociedad Española de Medicina de Familia y Comunitaria. semfyc ediciones]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
